The vaccine arm of Hualan Biological Engineering will be the first Chinese company to produce Russia's promising COVID-19 vaccine, Sputnik V, the company said.
In an announcement issued late Monday, the publicly traded Hualan said its vaccine unit's deal includes a technology transfer agreement that will provide the necessary capabilities to make the inoculation. Once production begins, the Hualan unit expects to receive orders for at least 100 million doses of the viral vector vaccine -- enough to vaccinate 50 million people.
